These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 34276654)

  • 1. Pre-Treatment Neutrophil Count as a Predictor of Antituberculosis Therapy Outcomes: A Multicenter Prospective Cohort Study.
    Carvalho ACC; Amorim G; Melo MGM; Silveira AKA; Vargas PHL; Moreira ASR; Rocha MS; Souza AB; Arriaga MB; Araújo-Pereira M; Figueiredo MC; Durovni B; Lapa-E-Silva JR; Cavalcante S; Rolla VC; Sterling TR; Cordeiro-Santos M; Andrade BB; Silva EC; Kritski AL;
    Front Immunol; 2021; 12():661934. PubMed ID: 34276654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Neutrophil Count and Decreased Neutrophil CD15 Expression Correlate With TB Disease Severity and Treatment Response Irrespective of HIV Co-infection.
    Ndlovu LN; Peetluk L; Moodley S; Nhamoyebonde S; Ngoepe AT; Mazibuko M; Khan K; Karim F; Pym AS; Maruri F; Moosa MS; van der Heijden YF; Sterling TR; Leslie A
    Front Immunol; 2020; 11():1872. PubMed ID: 32983107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
    Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
    BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria.
    Agizew T; Boyd R; Mathebula U; Mathoma A; Basotli J; Serumola C; Pals S; Finlay A; Lekone P; Rankgoane-Pono G; Tlhakanelo T; Chihota V; Auld AF
    PLoS One; 2020; 15(6):e0234646. PubMed ID: 32530972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood neutrophil counts in HIV-infected patients with pulmonary tuberculosis: association with sputum mycobacterial load.
    Kerkhoff AD; Wood R; Lowe DM; Vogt M; Lawn SD
    PLoS One; 2013; 8(7):e67956. PubMed ID: 23874476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
    Kawasaki M; Echiverri C; Raymond L; Cadena E; Reside E; Gler MT; Oda T; Ito R; Higashiyama R; Katsuragi K; Liu Y
    PLoS Med; 2019 Apr; 16(4):e1002780. PubMed ID: 30978194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study.
    Drain PK; Gounder L; Grobler A; Sahid F; Bassett IV; Moosa MY
    BMJ Open; 2015 Apr; 5(4):e006833. PubMed ID: 25877271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Blood Neutrophil Count After 1 Month of Treatment Predicts the Radiologic Severity of Lung Disease at Treatment End.
    Jones TPW; Dabbaj S; Mandal I; Cleverley J; Cash C; Lipman MCI; Lowe DM
    Chest; 2021 Dec; 160(6):2030-2041. PubMed ID: 34331904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV.
    Machowski EE; Letutu M; Lebina L; Waja Z; Msandiwa R; Milovanovic M; Gordhan BG; Otwombe K; Friedrich SO; Chaisson R; Diacon AH; Kana B; Martinson N
    BMC Infect Dis; 2021 May; 21(1):466. PubMed ID: 34022850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study.
    Namugenyi J; Musaazi J; Katamba A; Kalyango J; Sendaula E; Kambugu A; Fehr J; Castelnouvo B; Manabe YC; Ssengooba W; Sekaggya-Wiltshire C
    BMC Infect Dis; 2021 Jun; 21(1):513. PubMed ID: 34074248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cohort study on association between catastrophic costs and unfavorable tuberculosis treatment outcomes among TB-HIV and TB-diabetes comorbid patients in India.
    Rupani MP; Vyas S; Shah IA
    BMC Public Health; 2024 Jul; 24(1):2028. PubMed ID: 39075416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
    Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublineages of Mycobacterium tuberculosis Beijing genotype strains and unfavorable outcomes of anti-tuberculosis treatment.
    Hang NT; Maeda S; Keicho N; Thuong PH; Endo H
    Tuberculosis (Edinb); 2015 May; 95(3):336-42. PubMed ID: 25732626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Complexities Among Patients with Tuberculosis in a High HIV Prevalence Cohort in the United States.
    Bizune DJ; Kempker RR; Kagei M; Yamin A; Mohamed O; Holland DP; Oladele A; Wang YF; Rebolledo PA; Blumberg HM; Ray SM; Schechter MC
    AIDS Res Hum Retroviruses; 2018 Dec; 34(12):1050-1057. PubMed ID: 30105915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of alcohol consumption on tuberculosis treatment outcomes: a prospective longitudinal cohort study protocol.
    Myers B; Bouton TC; Ragan EJ; White LF; McIlleron H; Theron D; Parry CDH; Horsburgh CR; Warren RM; Jacobson KR
    BMC Infect Dis; 2018 Sep; 18(1):488. PubMed ID: 30268101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric tuberculosis outcomes and factors associated with unfavorable treatment outcomes in Botswana, 2008-2019: a retrospective analysis.
    Siamisang K; Rankgoane-Pono G; Madisa TM; Mudiayi TK; Tlhakanelo JT; Mubiri P; Kadimo K; Banda FM; Setlhare V
    BMC Public Health; 2022 Nov; 22(1):2020. PubMed ID: 36333805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.
    Mzinza DT; Sloan DJ; Jambo KC; Shani D; Kamdolozi M; Wilkinson KA; Wilkinson RJ; Davies GR; Heyderman RS; Mwandumba HC
    Tuberculosis (Edinb); 2015 Jul; 95(4):463-9. PubMed ID: 26051653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia and anti-tuberculosis treatment outcome in persons with pulmonary tuberculosis: A multi-center prospective cohort study.
    Araújo-Pereira M; Nogueira BMF; Spener-Gomes R; Carvalho ACC; Sant'Anna FM; Figueiredo MC; Turner MM; Kritski AL; Cordeiro-Santos M; Rolla VC; Sterling TR; Andrade BB;
    J Infect Public Health; 2023 Jun; 16(6):974-980. PubMed ID: 37121049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.